Comparing Imitation and Stereotyped Behaviors in Autistic Children: Robots vs. Human Operators

Sponsor
Istituto per la Ricerca e l'Innovazione Biomedica (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06144528
Collaborator
Comune di Messina (Other)
30
1
5
6

Study Details

Study Description

Brief Summary

Virtual QT is a social robot designed to interact with humans in social and educational contexts. Equipped with visual and vocal interfaces, the robot can recognize and respond to various human inputs, providing emotional support and social interaction.

It uses facial expressions, gestures, and movements to communicate, encouraging engagement and supporting learning through playful and educational activities. Its ergonomic design and interactive approach make it suitable for both clinical and educational settings.

The aim of this study is to examine the effectiveness of the QTrobot in interventions for children with Autism Spectrum Disorder (ASD) and to assess whether children's attention and imitation are equally effective with the QTrobot compared to interacting with a human being.

Furthermore, the presence of significant differences between motor and expressive imitation, when interacting with the robot as opposed to a human interlocutor, will be investigated. A key aspect of this investigation is to assess whether the presence of the QTrobot can positively influence the repetitive or stereotyped behaviors exhibited by the children, compared to interaction with a person. Additionally, to further understanding, the children's heart rate will be monitored through the use of a sensor that will allow to evaluate how heart rate affects performance outcomes during interaction with the QTrobot and with a human being.

In this study, children will be recruited to take part in two separate sessions, both involving the same task. During the first session, the task will be carried out between the child and the human operator. Subsequently, in the same task, the child will interact with the QT robot. Throughout both task administrations, the child will wear a sensor to detect their heart rate. Furthermore, all task sessions will be video-recorded to conduct subsequent video analysis and make notes on imitation behaviors and stereotypical actions relevant to the study.

Condition or Disease Intervention/Treatment Phase
  • Other: QT robot

Study Design

Study Type:
Observational
Anticipated Enrollment :
30 participants
Observational Model:
Case-Only
Time Perspective:
Cross-Sectional
Official Title:
Exploring Imitative Abilities and Stereotypies: Comparing Robots and Human Operators in Autistic Children
Anticipated Study Start Date :
Dec 1, 2023
Anticipated Primary Completion Date :
Feb 28, 2024
Anticipated Study Completion Date :
Apr 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Children with autism spectrum condition

Thirty Autism Spectrum Disorder (ASD) children with medium-high functioning, aged 4 to 13 years, IQ > 75, in the absence of motor deficits due to another clinical condition.

Other: QT robot
In a single session each child will be video-recorded while performing the task. The participant subjects will perform the same task at two different times, once with the human operator and once with the Qt robot. Both tasks will have a duration of approximately 4 minutes. During the first minute, both the operator and the Qt will introduce themselves and ask four questions to the child to deepen the acquaintance. In the second minute, the operator/Qt will tell a story. In the third minute, the operator/Qt will ask to imitate 4 motor movements, while in the fourth minute, the operator/Qt will ask to imitate 4 facial expressions.

Outcome Measures

Primary Outcome Measures

  1. Video analysis of performance [The video analysis needs approximately 15 minutes per child]

    The videos of the interviews were analyzed by a single observer. For each child, the observer evaluated both the child's interactions, one with a person and another with the robot. The assessment included the child's attention, measured by the frequency and duration of the child's gazes towards the interaction partner. Additionally, the observer recorded the number of imitations of the partner's actions, limited to a maximum of four imitations. Finally, to evaluate repetitive and stereotyped behaviors, the observer counted the sequences of these behaviors and the number of repetitions within each sequence. A sequence was defined as a continuous repetition of the same behavior type, with pauses or interruptions considered as separate sequences. If the child paused and resumed the same or a different behavior, each restart was counted as a new sequence.

Secondary Outcome Measures

  1. Heart rate [The test needs approximately 30 minutes]

    The polar sensor detects the electrical activity of the heart and calculates heart rate in beats per minute (bpm).Typically it is worn on the wrist or chest.

  2. Heart rate variability [The test needs approximately 30 minutes]

    The Polar sensor measures the time intervals between successive heart beats and calculates Heart Rate Variability (HRV) in milliseconds (ms). Typically it is worn on the wrist or chest.

Eligibility Criteria

Criteria

Ages Eligible for Study:
4 Years to 13 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Diagnosis of Autism

  • QI ≥ 75

Exclusion Criteria:
  • Motor deficits due to another clinical condition

Contacts and Locations

Locations

Site City State Country Postal Code
1 Institute for Biomedical Research and Innovation (IRIB) - National Research Council (CNR) Messina Italy 98164

Sponsors and Collaborators

  • Istituto per la Ricerca e l'Innovazione Biomedica
  • Comune di Messina

Investigators

  • Principal Investigator: Flavia Marino, Institute for Biomedical Research and Innovation (IRIB) - National Research Council (CNR)

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Flavia Marino, Head of Unit, Istituto per la Ricerca e l'Innovazione Biomedica
ClinicalTrials.gov Identifier:
NCT06144528
Other Study ID Numbers:
  • CNR-IRIB-PRO-2023-005
First Posted:
Nov 22, 2023
Last Update Posted:
Nov 22, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Flavia Marino, Head of Unit, Istituto per la Ricerca e l'Innovazione Biomedica
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 22, 2023